NYSE:TMOLife Sciences
Thermo Fisher Scientific (NYSE:TMO) Collaborates With RoosterBio To Advance Cell Therapy Solutions
Thermo Fisher Scientific (NYSE:TMO) has announced a new collaboration with RoosterBio to enhance the availability of cell and exosome therapies for treating degenerative diseases, a development that aligns with their focus on advanced therapy manufacturing. Despite this promising partnership, the company's stock was flat over the past week, amidst a broader market rally led by strong tech earnings from companies like Microsoft and Meta. With the S&P 500 and Dow rising for consecutive...